GIGI MANUEL: Open Payments
NPI 1235430166 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 11 payments from 7 companies in 2025. Trend: 2023 $233 · 2024 $465 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| PFIZER INC. | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| ABBVIE INC. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $24 |
Products named: ENTYVIO, NURTEC ODT, JARDIANCE, TRELEGY ELLIPTA, LINZESS, TREMFYA, Ozempic.
Industry payments across FL — which companies pay providers there.
